Sandra S.
About Sandra S.
Sandra S. serves as the Senior Director of Patient Advocacy and Engagement at Mirati Therapeutics, bringing over 25 years of experience in the pharmaceutical industry, particularly in oncology and patient engagement. She has held various leadership roles, including positions at MJH Life Sciences™, Merck, and the GO2 Foundation for Lung Cancer.
Work at Mirati Therapeutics
Sandra S. has been serving as the Senior Director of Patient Advocacy and Engagement at Mirati Therapeutics since 2021. In this role, she focuses on developing and implementing strategies that enhance patient engagement and advocacy efforts within the organization. Her work involves collaborating with various stakeholders to ensure that patient needs are prioritized in the development of oncology therapies.
Previous Experience at MJH Life Sciences™
Before joining Mirati Therapeutics, Sandra S. worked at MJH Life Sciences™ as Vice President of Strategic Alliance and Patient Engagement Strategy from 2020 to 2021. During her tenure, she was responsible for fostering strategic partnerships and enhancing patient engagement initiatives, contributing to the organization's mission of improving health outcomes.
Career at Merck
Sandra S. has extensive experience at Merck, where she held multiple roles over a span of 16 years. She worked in Advocacy and Professional Affairs from 2001 to 2017, focusing on building relationships within the healthcare community. Prior to that, she served as a Market Research Manager from 1996 to 2000, where she contributed to market insights and strategic planning.
Experience at GO2 Foundation for Lung Cancer
From 2017 to 2020, Sandra S. was the Director at GO2 Foundation for Lung Cancer. In this position, she led initiatives aimed at supporting lung cancer patients and their families, leveraging her advocacy skills to enhance awareness and access to resources for those affected by the disease.
Education and Expertise
Sandra S. holds a Bachelor of Science degree in Biomedical Science from Texas A&M University and an MBA in Health Services Management from The University of Dallas. With over 25 years of experience in the pharmaceutical industry, she possesses a diverse skill set that includes strategic planning, medical education, patient engagement strategy, and relationship management. Her background enables her to effectively communicate and advocate for patient needs in oncology.